4/3
08:04 am
bmrn
Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks [Yahoo! Finance]
Low
Report
Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks [Yahoo! Finance]
4/2
08:12 pm
bmrn
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock [Yahoo! Finance]
Low
Report
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock [Yahoo! Finance]
4/2
09:00 am
bmrn
BioMarin Announces Positive Pivotal Data for PALYNZIQ® (pegvaliase-pqpz) in Adolescents with Phenylketonuria
Low
Report
BioMarin Announces Positive Pivotal Data for PALYNZIQ® (pegvaliase-pqpz) in Adolescents with Phenylketonuria
4/1
11:03 pm
bmrn
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Low
Report
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
3/24
06:18 am
bmrn
Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks [Yahoo! Finance]
Low
Report
Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks [Yahoo! Finance]
3/21
08:09 pm
bmrn
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock [Yahoo! Finance]
Low
Report
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock [Yahoo! Finance]
3/21
05:58 pm
bmrn
BioMarin (BMRN) Up 4.2% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]
Low
Report
BioMarin (BMRN) Up 4.2% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]
3/21
06:46 am
bmrn
Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN) [Yahoo! Finance]
Low
Report
Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN) [Yahoo! Finance]
3/20
10:02 am
bmrn
Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks [Yahoo! Finance]
Low
Report
Q4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks [Yahoo! Finance]
3/20
09:28 am
bmrn
The Exceptional Women Alliance Announces Selection of Dr. Roslyn F. Schneider [Yahoo! Finance]
Low
Report
The Exceptional Women Alliance Announces Selection of Dr. Roslyn F. Schneider [Yahoo! Finance]
3/20
09:00 am
bmrn
BioMarin Presents New Data Demonstrating Favorable Safety and Strong Adherence in Real-World Clinical Practice with VOXZOGO® (vosoritide) in Children Under 3 with Achondroplasia at 2025 American College of Medical Genetics and Genomics (ACMG) Annual Clini
Low
Report
BioMarin Presents New Data Demonstrating Favorable Safety and Strong Adherence in Real-World Clinical Practice with VOXZOGO® (vosoritide) in Children Under 3 with Achondroplasia at 2025 American College of Medical Genetics and Genomics (ACMG) Annual Clini
3/18
02:07 am
bmrn
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Low
Report
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
3/11
07:21 am
bmrn
Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair [Yahoo! Finance]
Low
Report
Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair [Yahoo! Finance]
3/11
07:00 am
bmrn
Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair
Low
Report
Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair
3/10
02:04 am
bmrn
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Low
Report
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
3/2
02:07 am
bmrn
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Low
Report
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
2/25
09:00 am
bmrn
BioMarin to Present at the TD Cowen 45th Annual Healthcare Conference on Tuesday, March 4 at 6:50 AM PT / 9:50 AM ET in Boston, MA
Low
Report
BioMarin to Present at the TD Cowen 45th Annual Healthcare Conference on Tuesday, March 4 at 6:50 AM PT / 9:50 AM ET in Boston, MA
2/24
05:09 pm
bmrn
BioMarin Announces Appointment of Timothy P. Walbert to Board of Directors [Yahoo! Finance]
Low
Report
BioMarin Announces Appointment of Timothy P. Walbert to Board of Directors [Yahoo! Finance]
2/24
04:05 pm
bmrn
BioMarin Announces Appointment of Timothy P. Walbert to Board of Directors
Medium
Report
BioMarin Announces Appointment of Timothy P. Walbert to Board of Directors
2/24
10:31 am
bmrn
Oppenheimer upgrades BioMarin on long term outlook [Yahoo! Finance]
Low
Report
Oppenheimer upgrades BioMarin on long term outlook [Yahoo! Finance]
2/24
08:15 am
bmrn
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $98.00 price target on the stock.
Low
Report
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $98.00 price target on the stock.
2/22
02:12 am
bmrn
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Low
Report
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
2/22
02:12 am
bmrn
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Low
Report
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
2/22
12:11 am
bmrn
Why BioMarin Pharmaceutical Stock Zoomed Almost 5% Higher Today [Yahoo! Finance]
Low
Report
Why BioMarin Pharmaceutical Stock Zoomed Almost 5% Higher Today [Yahoo! Finance]
2/20
06:14 pm
bmrn
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $94.00 price target on the stock.
Low
Report
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $94.00 price target on the stock.